Silence Therapeutics

Silence Therapeutics is a biotechnology company focused on developing innovative medicines that use a technology called RNA interference (RNAi). This approach allows the company to target and "silence" specific genes responsible for various diseases, such as rare genetic disorders and certain types of cancer. By precisely turning off disease-causing genes, Silence Therapeutics aims to create highly targeted treatments with the potential for fewer side effects. Their work represents a promising approach in modern medicine, harnessing the body's natural mechanisms to address complex health conditions.